Filter by ContentType
Navigating the opportunities and challenges in analytical development of flowcytometry for T cell therapy
Therese Choquette, Minh Ngoc Duong
25 November 2024
Innovator Insight
Utilizing an automation-on-demand analytical tool for cancer immunotherapy
Christoph Eberle
22 September 2023
Innovator Insight
Patient-derived organoids: an emerging platform to de-risk immunotherapy development
Sylvia F Boj, Andrea Bisso
09 May 2023
Innovator Insight
Assessing efficacy & MoA of mono & combo immunotherapies in preclinical humanized models
Kader Thiam, Arjun Surya, Edward van der Horst
25 April 2023
Innovator Insight
Enhancing non-viral gene editing, processing & expansion of T & NK cells
06 February 2023
Innovator Insight
Predicting patient response to immune-targeted therapies via interrogation of the tumor microenvironment
Mark Uhlik, Dr Caroline Fong
19 December 2022
Innovator Insight
Modulation of both tumor & T cell apoptosis to enhance CAR-T immunotherapy
Marco Ruella
19 December 2022
Innovator Insight
Improved lentivirus recovery by weak anion exchange capture
Lisa Marx
16 December 2022
Innovator Insight
Manufacturing NK cells for the clinic: the Spanish experience
Antonio Pérez-Martínez, Marty Giedlin, Mariam Ammari
14 December 2022
Innovator Insight
Process development optimization for GMP manufacturing: a CAR-T case study
Gary M Pigeau
12 December 2022
Innovator Insight
Optimizing cell proliferation and function for immunotherapy with recombinant growth factors and cytokines
Martin Keough
18 September 2022
Innovator Insight
Magnetic selection for consistent cellular starting material in autologous cell therapy manufacture
Rachel Perret, Kenneth Olsen
10 February 2022
Innovator Insight
Advancing engineered cell & gene therapy with precision gene editing
John Lambourne
26 January 2022
Innovator Insight
Enabling clinical grade manufacturing of gene-engineered NK cells
Nina Möker, Rizwan Romee, Evelyn Ullrich
05 January 2022
Innovator Insight
Gain deeper insights into the mechanisms of immune cell killing of tumor cells: accelerate your time to answer with integrated software analysis
N Bevan, T Dale, J Skolnik et al
08 December 2021
Innovator Insight
Cell-based therapies for cancer treatment: leveraging advanced flow cytometry for greater clinical insight
11 October 2021
Innovator Insight
Overcoming purification challenges in antibody therapeutics manufacturing with subdomain-specific affinity solutions
Laurens Sierkstra
07 September 2021
Innovator Insight
Scalable upstream process development for the suspension-based production of lentiviral vectors for CAR T cell therapies with multiparallel & benchtop bioreactor systems & DoE methodology
Diana Riethmüller, Dr Alengo Nyamay’antu, Dr Franziska Bollmann
08 July 2021
Innovator Insight
Optimizing antibody discovery strategy for clinical success of next-gen immuno-oncology therapeutics
Ilse Roodink, Patrick Ott, Nina Senutovitch
01 December 2020
Innovator Insight
Evolving the role of gene editing in cell therapy
Jonathan Frampton, Torsten Meissner, Tristan Thwaites
29 October 2020
Innovator Insight
Promising non-viral vector for efficient and versatile delivery of mRNA for antigen-specific immunotherapy
R Firdessa-Fite, J Postigo-Fernandez, V Toussaint-Moreau et al
29 October 2020
Innovator Insight